GSA CAPITAL PARTNERS LLP - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 143 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2016$113,000
-96.4%
13,554
-94.6%
0.01%
-94.1%
Q2 2015$3,104,000
+66.4%
251,065
+59.9%
0.12%
+60.8%
Q1 2015$1,865,000
+183.9%
156,973
+109.7%
0.07%
+111.4%
Q3 2014$657,000
+82.5%
74,852
+51.7%
0.04%
+118.8%
Q2 2014$360,00049,3520.02%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q2 2016
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 514,853$2,595,0002.23%
GARRISON BRADFORD & ASSOCIATES INC 98,001$494,0000.48%
Catalyst Capital Advisors LLC 380,896$1,920,0000.44%
Knoll Capital Management, LLC 160,585$809,0000.42%
Tekla Capital Management LLC 757,050$3,816,0000.38%
FULLER & THALER ASSET MANAGEMENT, INC. 524,800$2,645,0000.13%
Integre Asset Management, LLC 103,493$522,0000.12%
CAMBRIDGE TRUST CO 220,003$1,109,0000.10%
JAMISON EATON & WOOD INC /NJ 62,782$316,0000.09%
STONERIDGE INVESTMENT PARTNERS LLC 88,304$445,0000.09%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders